Surrey Heartlands

Joint Formulary & PAD

Alfacalcidol - Vitamin D deficiency and insufficiency

You are here : Home > Formulary Search > Alfacalcidol - Vitamin D deficiency and insufficiency

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Capsules
  • Oral drops
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Guidelines
SPC
Restrictions / Comments :
Important

Prevention or treatment of vitamin D deficiency in renal or cholestatic liver disease

Documentation

Policy Statement
Vitamin D - Policy statement PCN 116-2014 - Sep 2014

PAD Profile

ChemicalSubstance :
Alfacalcidol
Indication :
Vitamin D deficiency and insufficiency
Group Name :
Keywords :
vitamin D
Brand Names Include :
One-Alpha
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Vitamin D deficiency and insufficiency
Supporting Documents :
1

Other Indications

Below are listed other indications that Alfacalcidol is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Vitamin D deficiency and insufficiency.

Committee Recommendations (1)

03 May 17 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
Alfacalcidol has been considered by the PCN and has been assigned a GREEN traffic light status, within its LICENSED indication(s).

NOTE - the branded product (One-Alpha) was considered BLACK at the PCN in May 2017.